Caplin Point Laboratories Schedules Board Meeting on 12th Nov'26 for Q2 Financial Results
Caplin Point Laboratories Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Caplin Point Laboratories Schedules Board Meeting on 12th Nov'26 for Q2 Financial Results Caplin Point Laboratories Limited announced that its Board of Directors will meet on 12th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities by designated persons and their immediate relatives remains closed from 1st Oct'26 through 14th Nov'26.
Original exchange filing (PDF)
More announcements from Caplin Point Laboratories Ltd
- Classification of US FDA Inspection at the facility of Caplin Steriles Limited, subsidiary of the Company as OAI 路 17 Nov 2026
- Audio Recording of Earnings call for the Quarter and half year ended September 30, 2026 路 13 Nov 2026
- Investor Presentation for the Earnings Call for the Quarter and half year ended September 30, 2026 路 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 12 Nov 2026
- Board Meeting Outcome for Meeting Held on November 12, 2026 路 12 Nov 2026
- Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Analyst / investor Call for the quarter and half ended September 30, 2026 路 12 Nov 2026
- CAPLIN POINT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 12 Nov 2026
